| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Roberts Christopher D. is a Chief Scientific Officer at Black Diamond Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $17K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $26.64 | $66,602.25 | -43.9% | -64.3% | -91.4% | |
| Apr 5, 2021 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $25.54 | $63,847.50 | -43.9% | -54.1% | -89.3% | |
| Mar 3, 2021 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $26.10 | $65,261.83 | -25.6% | - | - | |
| Feb 3, 2021 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $25.35 | $63,375.00 | -43.9% | - | - | |
| Jan 4, 2021 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $31.41 | $78,524.67 | -26.5% | - | - | |
| Dec 3, 2020 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $32.42 | $81,055.25 | -100% | - | - | |
| Nov 11, 2020 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,000 | $34.90 | $174,500.00 | -100% | - | - | |
| Nov 3, 2020 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $31.95 | $79,873.00 | -100% | - | - | |
| Oct 5, 2020 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $31.28 | $78,187.74 | -91.7% | - | - | |
| Sep 3, 2020 | BDTX Black Diamond Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,500 | $29.59 | $73,987.40 | -51.5% | - | - |